 PTA alone. Patency at 1 year was 83.1%
for DES and 32.8% for PTA. In the 110 patients undergoing
salvage stenting for failed PTA, 1-year patency was signiÔ¨Åcantly better for DES compared with BMS (89.9% vs
73%).204 The patency superiority of paclitaxel DES over
PTA (74.